Skip to main content
. Author manuscript; available in PMC: 2015 Feb 10.
Published in final edited form as: Curr Opin Oncol. 2013 Nov;25(6):637–645. doi: 10.1097/CCO.0000000000000006

Figure 1. Overarching hypothesis.

Figure 1

Colon cancer is driven by microbial associated. Typically this is a TH17 inflammation that is controlled by IL-10-expressing T-cells and Tregs. There is also a general consensus that cancer is controlled by immune surveillance and TH1 response. Ultimately, disease outcome is the product of both control of inflammation and effective immune surveillance. IL-10 is essential for both processes.